mergers-and-acquisitions
HeadlinesSky-owner comcast in talks to buy ITV's broadcasting arm, Bloomberg news reports
Novo CEO says its bid for metsera is higher
FinanceNordic capital, permira takeover offer for bavarian nordic falls through
Italy's BPER beats profit forecast with pop sondrio merger contribution
Mediobanca profit falls 11.8% hit by MPS, banca generali bid costs
Date: November 5, 2025
MILAN (Reuters) -Italian merchant bank Mediobanca on Wednesday reported an 11.8% yearly fall in quarterly net profit, hit by costs tied to its defence against Banca Monte dei Paschi's (MPS) takeover...
Bunge profit tops estimates on strong processing margins, viterra boost
Date: November 5, 2025
(Reuters) -Grain trader Bunge beat Wall Street estimates for third-quarter adjusted profit on Wednesday, boosted by the closing of its acquisition of Viterra and by a recovery in processing margins...
Novo nordisk, pfizer sweeten bid for metsera as bidding war heats up
Date: November 4, 2025
(Reuters) -Novo Nordisk is now offering up to $10 billion for Metsera, up from its prior offer of up to $8.5 billion, the obesity drug developer said on Tuesday. (Reporting by Christy Santhosh and...
Pfizer accuses novo nordisk of anticompetitive plot to stall metsera deal in lawsuit
Date: November 3, 2025
(Reuters) -Pfizer Inc said on Monday it has filed a second lawsuit against Metsera, its controlling shareholder, and Novo Nordisk in a Delaware federal court, accusing the Danish drugmaker of...
UK regulator refers Getty-Shutterstock merger for an in-depth investigation
Date: November 3, 2025
(Reuters) -Britain's competition watchdog said on Monday it will launch an in-depth investigation into the proposed merger between U.S.-based Getty Images and rival Shutterstock after remedies offered...
Pfizer sues metsera, novo nordisk over rival obesity drug bid
Date: October 31, 2025
(Reuters) -Pfizer said on Friday it had filed a lawsuit against Metsera and Novo Nordisk , saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker's $8.5 billion bid...